167 related articles for article (PubMed ID: 33155930)
41. [Human papillomavirus E7 oncoprotein and its role in the cell transformation].
Vallejo-Ruiz V; Velázquez-Márquez N; Sánchez-Alonso P; Santos-López G; Reyes-Leyva J
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S172-7. PubMed ID: 26462513
[TBL] [Abstract][Full Text] [Related]
42. Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model.
Huang CY; Chen JJ; Shen KY; Chang LS; Yeh YC; Chen IH; Chong P; Liu SJ; Leng CH
PLoS One; 2012; 7(7):e40970. PubMed ID: 22815882
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical detection of E7 human papillomavirus protein in pre‑malignant and malignant lesions of the uterine cervix.
Shi L; Han F; Shi C; Huang Y; Liu Y; Chang X
Mol Med Rep; 2018 Oct; 18(4):3949-3956. PubMed ID: 30132548
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.
Chalertpet K; Pakdeechaidan W; Patel V; Mutirangura A; Yanatatsaneejit P
Cancer Sci; 2015 Oct; 106(10):1333-40. PubMed ID: 26250467
[TBL] [Abstract][Full Text] [Related]
45. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
47. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
[TBL] [Abstract][Full Text] [Related]
48. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
49. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
[TBL] [Abstract][Full Text] [Related]
50. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
51. A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
Bertagnin C; Messa L; Pavan M; Celegato M; Sturlese M; Mercorelli B; Moro S; Loregian A
Cancer Lett; 2023 Sep; 571():216331. PubMed ID: 37532093
[TBL] [Abstract][Full Text] [Related]
52. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
53. An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer.
Zou J; Li Y; Chen T; Zhu C
Transl Cancer Res; 2024 Apr; 13(4):1876-1886. PubMed ID: 38737678
[TBL] [Abstract][Full Text] [Related]
54. E2F1-mediated up-regulation of TOP2A promotes viability, migration, and invasion, and inhibits apoptosis of gastric cancer cells.
Chen YU; Yu Y; Lv M; Shi Q; Li X
J Biosci; 2022; 47():. PubMed ID: 36550695
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus E7 induces p63 expression to modulate DNA damage response.
Eldakhakhny S; Zhou Q; Crosbie EJ; Sayan BS
Cell Death Dis; 2018 Jan; 9(2):127. PubMed ID: 29374145
[TBL] [Abstract][Full Text] [Related]
56. Depletion of Human Papilloma Virus E6- and E7-Oncoprotein-Specific T-Cell Responses in Women Living With HIV.
Mbuya W; Held K; Mcharo RD; Haule A; Mhizde J; Mnkai J; Mahenge A; Mwakatima M; Sembo M; Mwalongo W; Agrea P; Hoelscher M; Maboko L; Saathoff E; Geisenberger O; Rwegoshora F; Torres L; Koup RA; Kroidl A; Chachage M; Geldmacher C
Front Immunol; 2021; 12():742861. PubMed ID: 34759925
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
58. ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer.
Zhang M; Song Y; Zhai F
J Cell Biochem; 2018 Jun; 119(6):4397-4407. PubMed ID: 29130509
[TBL] [Abstract][Full Text] [Related]
59. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
60. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
Peng X; Zhang Y; Gao J; Cai C
Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
